Introduction

Molecular Medicine Reports

1791-2997 1791-3004

D.A. Spandidos

10.3892/mmr.2019.10748

mmr-20-06-4763

Review

Aryl hydrocarbon receptor pathway: Role, regulation and intervention in atherosclerosis therapy

Zhu

Kaixi

1 2 * Meng

Qingqi

3 * Zhang

Zhi

4 * Yi

Tao

1 2 He

Yuan

2 Zheng

Jing

5 Lei

Wei

1 2

1Cardiovascular Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, P.R. China 2Laboratory of Cardiovascular Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, P.R. China 3Department of Orthopedics, Guangzhou Red Cross Hospital, Guangzhou, Guangdong 510000, P.R. China 4Department of Vascular, Thyroid and Breast Surgery, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China 5Department of Obstetrics and Gynecology, University of Wisconsin, Madison, WI 53715, USA

Correspondence to: Dr Wei Lei, Laboratory of Cardiovascular Diseases, Affiliated Hospital of Guangdong Medical University, 2 Wenming East Road, Xiashan, Zhanjiang, Guangdong 524001, P.R. China, E-mail: leiwei2006@126.com *

Contributed equally

122019

16102019

20 6 4763 4773 15012019 05052019

2019

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor originally isolated and characterized as the dioxin or xenobiotic receptor. With the discovery of endogenous ligands and studies of AhR knockout mice, AhR has been found to serve an important role in several biological processes, including immune responses and developmental and pathological regulation. In particular, it has been considered as a new major player in cardiovascular diseases. Recent studies have revealed that the development of atherosclerosis is closely associated with AhR function. However, the roles of the AhR in the pathological development of atherosclerosis and atherosclerosis-associated diseases remain unclear. The current review presents the molecular mechanisms involved in the regulation of AhR expression during inflammation, oxidative stress and lipid deposition. Additionally, the role of the AhR in atherosclerosis and atherosclerosis-associated diseases is reviewed.

AhR atherosclerosis inflammation lipid deposition endothelial cells

1. Introduction

The aryl hydrocarbon receptor (AhR) is ligand-dependent and mediates nuclear receptors that react with heterologous substances of phases I and II (Fig. 1). The theory of polycyclic aromatic compound (PAC) metabolic reactions was postulated in the late 1950s (1). The carcinogenic dye 3-methylcholanthrene induces the synthesis of a specific enzyme that detoxifies 3-methylcholanthrene by promoting the synthesis of the liver microsomal enzyme P450, which is an aryl hydrocarbon hydroxylase (AHH) (1). Other carcinogens, including insecticides and phenobarbital, have a similar effect. This increase in synthesis meets the criteria of an adaptive response, as the upregulated enzyme oxidizes the PAH inducer when it is re-exposed within a short timeframe (2–4). Genetic studies have revealed that AHH is regulated by multiple alleles. These alleles were originally called Ah and used to describe the reaction of aromatic hydrocarbons (5).

The AhR belongs to the basic helix-loop-helix (bHLH) family and has a Per-Arnt-Sim (PAS) domain that binds to a variety of endogenous and exogenous chemicals. It binds specific auxiliary proteins, including heat shock protein 90 and hepatitis B virus X-associated protein, in the cytoplasm of resting state cells (6,7). When the AhR is transferred to the nucleus, it combines with the aryl hydrocarbon receptor nuclear translocator and triggers the transcription of several downstream genes, including cytochrome P450 family 1 subfamily A member 1 (CYP1A1) and cytochrome P450 family 1 subfamily B member 1 (CYP1B1), resulting in a variety of physiological and toxicological effects (8) (Fig. 2). Aryl hydrocarbon receptors are polymorphic. Known alleles include AhRb-1–3 and AhRd (9). The receptors have different affinities, however; all four proteins are alkaline and contain a bHLH as well as PAS and transactivation domains (10).

The sensitivity of AhR to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is species-specific, and its persistence in different organs in vivo varies according to the expression pattern of AhR in the specific organ (11). The AhR is most highly expressed in the human placenta, followed by the lungs, heart, pancreas and liver. Its lowest expression levels are in the kidney, brain and skeletal muscle (9). The AhR is transcribed from highly conserved sequences and plays a regulatory role in system development and physiological processes of different organs. Therefore, its expression is of great importance. The AhR is activated by the high-affinity exogenous ligands HAH and PAH as well as low-affinity endogenous ligands such as arachidonic acid, pyrene, and tryptophan and flavonoid derivatives (12–14). The endogenous ligands activate the AhR to participate in the regulation of cardiac functions, vascular development and blood pressure (15–19). In addition, the AhR signaling pathway senses changes in the circadian rhythm, oxygen tension and redox potential to regulate neural development and vacularization (20). For example, exposure to polycyclic aromatic hydrocarbons in cigarette smoke results in oxidative stress and the production of oxidized low-density lipoprotein (ox-LDL). ox-LDL accumulation in macrophages and smooth muscle-derived pro-inflammatory foam cells is a hallmark of atherosclerosis (21).

Studies using AhR^−/− mice have revealed that the AhR is a vital regulator of growth, development and material metabolism (22,23). Recent reports revealed that the AhR may exert harmful effects relating to endothelial dysfunction and immune disorders (24,25). AhR ligands activate the inflammatory axis in vascular endothelial cells to promote cell apoptosis and the inflammatory response (26).

The aim of the present review was to discuss the nature of the AhR, mediation of exogenous drugs, and potential targets for modification of cardiovascular genes. The role of the AhR receptor in the cardiovascular system, particularly the mechanism of action of AhR in atherosclerosis, is discussed in the present review. The role of the AhR in the development of novel therapeutic agents for the treatment of cardiovascular diseases is also presented.

2. AhR regulation in atherosclerosis pathogenesis

Atherosclerosis is a chronic inflammatory disease (27,28). The pathology of atherosclerosis can be summarized as follows. Foreign or endogenous substances, such as PAHs, PCBs and indoleamine 2,3-dioxygenase, cause oxidative stress, inflammation and the release of interleukin (IL) 1 and tumor necrosis factor (TNF) which stimulate chemokines, vascular endothelial cells, vascular endothelial cells, or neutrophils in the vascular interstitium (29,30). Inflammatory factors induce the oxidation of low-density lipoproteins which are phagocytized by macrophages which subsequently become lipid lines (31). The inflammatory factors induce the chemotaxis of monocytes in blood vessels into the stromal cells, where they differentiate into macrophages (32,33). This is the early development of atherosclerosis (34). Lipids (mainly cholesterol) are deposited in the intima of large and medium blood vessels (35,36). Smooth muscle cells and collagen fibers increase in number, and, secondary to necrosis, atheromatous plaques form. The plaques often cause different degrees of stenosis of the vascular lumen (37). Diseases with hardening of the blood vessel wall may present with ischemic changes in the end organs.

<sec> <title>AhR signaling pathway in inflammation and atherosclerosis

Atherosclerosis is an inflammatory immune disease; it's inflammatory etiology was first proposed by Ross (28). Nuclear factor κ-B (NF-κB) is a key signal transduction factor and plays a central role in inflammatory cytokine-mediated inflammatory responses. When cells are stimulated by various internal factors including SRC-1 and p300, the NF-κB signaling pathway is activated, and nuclear factors combine with the corresponding genes, thereby regulating the expression of target genes that magnify the inflammatory response, such as chemokines, inflammatory cytokines (including TNF-α, IL-1 and IL-6) and adhesion molecules [including intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 (VCAM-1)] (29,38). In the cytoplasm, AhR competitively binds to the RELA proto-oncogene, NF-κB subunit (RELA) in NF-κB in a ‘tethered’ manner, preventing the AhR from combining with a required synergistic activator (39). By binding to the promoter of AhR-NF-κB1, RELA regulates the promoter sequence, affecting the expression of the AhR (40). In the coronary endothelium, whether the AhR signaling pathway exerts adverse effects on physiological functions through the NF-κB signaling pathway remains unreported (41).

There are three hypotheses underlying the AhR signaling pathways that mediate inflammation and promote atherosclerosis. The first hypothesis involves the signaling of downstream inflammatory factors such as VCAM-1 via the AhR/NF-κB signaling pathway, which leads to monocyte chemotaxis (42). Macrophages and monocytes are targeted by polycyclic aromatic hydrocarbons involved in the physiological and pathological processes of atherosclerosis (43). The second hypothesis postulates that the AhR promotes macrophages absorption of ox-LDL to form foam cells by mediating endogenous and exogenous ligands such as ox-LDL, lipopolysaccharides and TCDD. In vitro studies have revealed that cholesterol accumulation in foam cells caused by particulate matter-induced inflammation is an early sign of cardiovascular disease (30,44). However, the inhibitory effect of AhR inhibitors on foam cells and inflammation have not been investigated. It is believed that these mechanisms will be elucidated by extensive research of the AhR. The third hypothesis involves the increased proliferation of vascular smooth muscle cells (VSMCs), which is a critical factor in the occurrence of vascular complications. Yisireyili et al (45) exposed VSMCs to indoxyl sulfate, an agonist of AhR. Indoxyl sulfate induces VSMC proliferation via the activation of the AhR, the NF-κB signaling pathway and reactive oxygen species (ROS) production (Fig. 3).

AhR signaling pathway in oxidative stress and atherosclerosis

AhR mediates exogenous chemicals, such as TCDD and dioxin-like planar polychlorinated biphenyls (PCBs), and endogenous substances, including indoxyl sulfate and arachidonic acid, by activating NADPH oxidase to produce ROS that directly damages vascular endothelial cells. This may result in a cellular oxidative stress/antioxidant imbalance that leads to cell damage and reduces the integrity of the vascular endothelium (46,47). Previous studies have revealed that ROS mediate the transcription of specific genes, such as NF-κB, which mediate the transcription of inflammatory inducible nitric oxide synthase (44,48).

AhR signaling pathway in lipid deposition and atherosclerosis

Lipid deposition is an essential external condition for foam cell formation (49). The current clinical treatment mainly relies on lipid-lowering drugs such as atorvastatin and fenofibrate (50). Lipid metabolism mainly occurs in the liver. It has been validated by recent studies that the AhR not only detoxifies, but also regulates lipid metabolism in the liver (51). Environmental pollutants such as TCDD and benzo(a)pyrene (BP) inhibit the expression of NPC intracellular cholesterol transporter 1 in an AhR-dependent manner, promoting lipid deposition (52).

Lipid deposition can be induced by several AhR ligands. TCDD is a classical AhR ligand. A previous study revealed that α-endosulfan and 2,3,7,8-TCDD jointly downregulate the expression of glucose- and lipid-associated genes in the liver, such as nuclear receptor subfamily 1 group H member 4 and nuclear receptor binding factor 2 (53). Lipoxin A4 (LXA4), an endogenous ligand of AhR, is induced by homocysteine in patients with hyperhomocysteinemia. LXA4 promotes the binding of the AhR to the promoter of CD36 in hepatocytes and promotes CD36 expression, which increases the uptake of fatty acids and lipid accumulation by hepatocytes (54). Previous studies revealed that AhR activation affects the systemic metabolic functions of mice, including suppressed tricarboxylic acid cycle, disrupted lipid metabolism, amino acids metabolism, glycogenolysis, gluconeogenesis, thereby increased hepatic lipogenesis, and promotedinflammatory signaling pathways (23,55,56).

AhR knockout mice are widely used to study the role of the AhR in physiological functions. Activation of AhR protects against fatty liver induced by insulin resistance by activating fibroblast growth factor 21 (FGF21) to regulate lipid and energy metabolism in such mice (57). AhR knockout mice have increased levels of energy metabolism compared with normal mice, which protects against insulin resistance, hepatic steatosis, obesity and inflammation caused by a high-fat diet (HFD) (23). By contrast, the AhR protects against hepatic steatosis induced by a HFD and subsequent lipotoxicity. The AhR protects against fatty liver induced by insulin resistance by activating FGF21. The endocrine signaling pathway of AhR and FGF21 suggests that AhR is a crucial environmental modifier that combines signals from chemical exposure to regulate lipid and energy metabolism (57). In vivo experiments have revealed that locked nucleic acid 29, an inhibitor of microRNA (miR)-29, inhibits lipid deposition in the liver, and whole-genome analysis demonstrated increased AhR and sirtuin1 expression (58). AhR is a direct target gene of miR-29. Therefore, it may be an alternative therapeutic target for treating metabolic disorders such as dyslipidemia (58). PCB 153, mediated by AhR, can be considered as a ‘secondary strike’ mechanism for obesity/non-alcoholic fatty liver disease in the context of a HFD (59).

3. Clinical research about AhR and atherosclerosis-associated diseases

Studies investigating the association of the AhR signaling pathway and its downstream genes, glutathione S-transferase μ1 (GSTM1) and glutathione S-transferase θ1 (GSTT1), with the risk and complications of atherosclerosis-associated diseases have yielded inconclusive results (60,61). Recent studies revealed that AhR may be associated with atherosclerosis-associated diseases, including coronary artery disease (CAD), ischemic stroke and type 2 diabetes mellitus (T2DM) (62–64) (Table I). The current review presents clinical research to reveal their association.

<sec> <title>Role of the AhR in the occurrence and development of CAD

CAD may result in mortality and is associated with atherosclerosis and thrombosis (65). There is no clinically relevant research on AhR gene polymorphisms and atherosclerosis, to the best of our knowledge, and few studies on AhR gene polymorphism and CAD (66–68). Receiver operating characteristic analysis of 939 patients with confirmed CAD and 868 normal subjects indicated that the AhR is a potential marker for objective measurement and evaluation of CAD in addition to other cardiac markers, such as creatine kinase-MB (69). Genotype frequencies of AhR rs2066853 reveal significant differences between CAD and control subjects, and hyperlipidemia and smoking significantly increased the risk of CAD associated with AhR polymorphism (69). Furthermore, the four subtypes of CAD with varying severity show significant differences in the distribution of AhR variants (70). Previous studies have investigated the association of CAD and the downstream mediators of the AhR signaling pathway, CYP1A1, GSTT1 and GSTM1, that mediate the metabolism of allogenic toxic substances (Table I). Previous studies in China have demonstrated significant associations of CYP1A1, GSTM1, GSTT1 and peroxisome proliferator activated receptor γ with CAD, particularly in smokers (70–72).

A cross-sectional study in Croatia included 252 adult subjects with suspected exposure to PAHs; it was revealed that CYP1A1, GSTM1 and GSTT1 gene polymorphisms had no association with the risk of CAD (73).

Previous studies in India have demonstrated an association between GSTM1/GSTT1/glutathione S-transferase π1 (GSTP1) polymorphism, coronary heart disease and blood lipid parameters (74–76). These findings suggest that blood lipid parameters in patients with coronary angiography are significantly associated with GSTM1/T1/P1 genotype distribution and GSTT1 deletion polymorphisms. However, a case-control study in the Republic of Korea revealed that GSTM1/T1 had no effect on the degree of lumen stenosis in CAD (77). Smokers carrying a GSTM1/T1 mutation have a higher risk of CAD (77).

Regarding the association between genetic polymorphisms of GSTM1 and smoking-related CAD, smokers with the GSTM1 null genotype have a greater risk of CAD compared with non-smokers with the GSTM1-positive genotype [odds ratio (OR), 2.07; 95% confidence interval (CI), 1.06–4.07]. The association between genetic polymorphisms of GSTT1 and smoking related-CAD smoking shares the same tendency as that for GSTM1 (OR, 2.00; 95% CI, 1.05–3.84). The association between GSTM1 and GSTT1 null genotypes in smoking-related CAD was also augmented when genetic polymorphisms of GSTM1 and GSTT1 were considered simultaneously (OR, 2.76; 95% CI, 1.17–6.52) (77). On the basis of several epidemiological studies, AhR downstream genes are significantly associated with CAD, particularly in smokers with the GSTT1/M1 knockout gene (78–80).

AhR mRNA and the mRNA level of its allele are higher in the peripheral blood of patients with CAD compared with controls (69). Smoking increases the risk of CAD in patients with AhR gene polymorphisms. This may be due to the aromatic hydrocarbons present in smoke which cause lipid metabolism through the AhR signaling pathway (81). Furthermore, nicotine exposure induces VCAM-1, matrix metalloprotein (MMP)-2 and MMP-9 production in VSMCs and macrophages (82) and promotes vascular oxidative stress, leading to vascular damage (83).

AhR expression and polymorphisms are associated with the risk of ischemic stroke

Ischemic stroke is regarded as a potentially fatal disease (84) that occurs when there is a sudden decrease of blood supply to brain tissue, resulting in ischemia and hypoxia. Although cerebral and myocardial infarctions have different sites, the pathological mechanism is atherosclerosis (85). Therefore, cerebral infarction may be associated with vascular inflammation and oxidative stress; AhR downstream genes, such as CYP1A1, GSTT1 and GSTM1, may serve important roles in the pathogenesis (86) (Table I).

A case-control study in Turkey, which included 226 patients with ischemic stroke and 113 controls, showed significant differences between 6235C allele and the risk of ischemic stroke, particularly in smokers and patients with hypertension (87).

Moon et al (86) investigated 353 patients with cerebral infarction and 376 controls. A significantly larger number of patients with cerebral infarction had the CYP1A1 gene 3′-flanking region (T6235C) compared with the controls (P=0.017; OR, 1.44; 95% CI, 1.07–1.94). Analysis of gene-gene interactions showed that the GSTM1 null genotype increased the cerebral infarction risk in carriers of the CYP1A1 C allele (P=0.015; OR, 1.47; 95% CI, 1.08–2.00) (86).

To investigate the association between stroke and polymorphism of the CYP1A1 gene, Sultana et al (88) selected 215 patients with ischemic stroke and 162 age-matched controls. The results indicated that ischemic stroke had a significant association with the CYP1A1 genotype ‘CC’ (P=0.01; OR, 5.14; 95% CI, 1.14–23.14) in south Indian population, whereas Zhang et al (89) showed that CYP1A1 decreased the risk of disease in the eastern Han of China, and this contradiction showed CYP1A1 gene to display distinct alleles distribution among populations. In conclusion, CYP1A1 was shown to be significantly associated with ischemic stroke in certain clinical studies; however, further investigation is required to verify this association.

Association of AhR and its downstream genes with T2DM

T2DM, a metabolic disease, is associated with oxidative stress and chronic inflammation in adipose tissue (90). Previous epidemiological studies have revealed associations between oxidative stress-associated enzymes, such as GSTT1 and GSTM1, and diabetes (Table I). GSTT1 and GSTM1 are AhR downstream genes.

A case-control study in India revealed that GSTM1 and GSTT1 are associated with gene polymorphism-associated fat mass and obesity. GSTM1-positive and GSTM1 null genotypes had significant associations with T2DM, but there was no significant association with FTO α-ketoglutarate-dependent dioxygenase polymorphism (91). Other epidemiological studies revealed that GSTM1 and GSTT1 did not have significant effects on T2DM (92,93). Hori et al (94) did not reveal a significant association between T2DM and GSTT1/M1 gene alleles, but the incidence rate of T2DM in GSTT1 and GSTM1 null genotypes was 1.5-fold higher than that in GSTM1 and GSTT1 positive genotypes. The aforementioned clinical studies demonstrated that GSTT1/M1 and diabetes are not highly associated and that further investigation is required to determine their associations.

4. Conclusion

The current review presented the association between the AhR and inflammation, oxidative stress, lipid infiltration and atherosclerosis. The AhR is closely associated with cardiovascular disease in terms of cardiac function, vascular development and blood pressure regulation (Fig. 4). In certain atherosclerosis-associated diseases, the AhR may serve a role as an oxidative stress signal transmitter. The AhR may be a potential target for the clinical treatment of cardiovascular disease. However, some important questions remain unanswered. The regulation of the AhR at the gene level has not been elucidated in humans. There are currently no drugs targeting the AhR in the clinic. The AhR is associated with other signaling pathways, including the Wnt and E2 factor signaling pathways, and further basic experiments are required to elucidate the roles of the AhR. The identification of novel endogenous ligands and the application of AhR knockout mice may clarify the role, regulation and intervention of the AhR in the treatment of atherosclerosis.

Acknowledgements

Not applicable.

Funding

The present study was supported by the National Natural Science Foundation of China (grant nos. 81700269 and 81741129), the Collaborative Innovation and Platform Environment Construction Projects of Guangdong Province (grant no. 2015A050502049) and the Characteristic Innovation Project of Department of Education of Guangdong Province (grant no. 2016KTSCX048).

Availability of data and materials

Not applicable.

Authors' contributions

WL and JZ conceived and designed the review. KZ retrieved the relevant literature and wrote the manuscript. TY provided a figure. QM, ZZ and YH reviewed and edited the manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Abbreviations

AhR

aryl hydrocarbon receptor

PAC

polycyclic aromatic compound

AHH

aryl hydrocarbon hydroxylase

bHLH

basic helix-loop-helix

PAS

Per-Arnt-Sim

VSMCs

vascular smooth muscle cells

ROS

reactive oxygen species

FGF21

fibroblast growth factor 21

CAD

coronary artery disease

T2DM

type 2 diabetes mellitus

CYP1A1

cytochrome P450, family 1, subfamily A, polypeptide 1

interleukin

ox-LDL

oxidized low-density lipoprotein

NF-κB

nuclear factor kappa-B

TNF

tumor necrosis factor

VCAM-1

vascular cell adhesion molecule-1

PCBs

planar polychlorinated biphenyls

TCDD

2,3,7,8-tetrachlorodibenzo-p-dioxin

MMP

matrix metalloproteinase

LXA4

lipoxin A4

HFD

high-fat diet

odds ratio

confidence interval

References 1

Conney

Miller

The metabolism of methylated aminoazo dyes v. evidence for induction of enzyme synthesis in the rat by 3-methylcholanthre

Cancer Res164504591956

13330038

Huang

Wei

Ren

Mburu

Tian

Transcription factors CncC/Maf and AhR/ARNT coordinately regulate the expression of multiple GSTs conferring resistance to chlorpyrifos and cypermethrin in spodoptera exigua

Pest Manag Sci75200920192019

10.1002/ps.5316

30610747

Higgins

Hayes

Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents

Drug Metab Rev43921372011

10.3109/03602532.2011.567391

21495793

De Anna

Leggieri

Arias Darraz

Cárcamo

Venturino

Luquet

Effects of sequential exposure to water accommodated fraction of crude oil and chlorpyrifos on molecular and biochemical biomarkers in rainbow trout

Comp Biochem Physiol C Toxicol Pharmacol21247552018

10.1016/j.cbpc.2018.07.003

30012402

Davisson

Rules and guidelines for genetic nomenclature in mice: Excerpted version

Transgenic Res63093191997

10.1023/A:1018466830035

9322368

Baricza

Tamási

Marton

Buzás

Nagy

The emerging role of aryl hydrocarbon receptor in the activation and differentiation of Th17 cells

Cell Mol Life Sci73951172016

10.1007/s00018-015-2056-2

26511867

Schmidt

Bradfield

Ah receptor signaling pathways

Annu Rev Cell Dev Biol1255891996

10.1146/annurev.cellbio.12.1.55

8970722

Hwang

Choi

Cytochrome P450 1 family and cancers

J Steroid Biochem Mol Biol14724302015

10.1016/j.jsbmb.2014.11.003

25448748

Zhang

The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology

J Cardiovasc Dis Res291952011

10.4103/0975-3583.83033

21814412

3144625

Curran

Altenhofen

Ashworth

Brown

Kamau-Cheggeh

Curran

Evans

Floyd

Fowler

Garber

Ahr^dCyp1a2(−/−) mice show increased susceptibility to PCB-induced developmental neurotoxicity

Neurotoxicology33143614422012

10.1016/j.neuro.2012.08.005

22935098

3518762

Bock

From TCDD-mediated toxicity to searches of physiologic AHR functions

Biochem Pharmacol1554194242018

10.1016/j.bcp.2018.07.032

30055148

Tian

Rabson

Gallo

Ah receptor and NF-κB interactions: Mechanisms and physiological implications

Chem Biol Interact141971152002

10.1016/S0009-2797(02)00068-6

12213387

Stejskalova

Dvorak

Pavek

Endogenous and exogenous ligands of aryl hydrocarbon receptor: Current state of art

Curr Drug Metab121982122011

10.2174/138920011795016818

21395538

Lamas

Natividad

Sokol

Aryl hydrocarbon receptor and intestinal immunity

Mucosal Immunol11102410382018

10.1038/s41385-018-0019-2

29626198

Wakamatsu

Yamamoto

Ito

Sato

Matsuo

Takahashi

Kaneko

Goto

Kazama

Gejyo

Narita

Indoxyl sulfate promotes macrophage IL-1β production by activating aryl hydrocarbon receptor/NF-κ/MAPK cascades, but the NLRP3 inflammasome was not activated

Toxins (Basel)10E1242018

10.3390/toxins10030124

29543732

Nishiumi

Yamamoto

Kodoi

Fukuda

Yoshida

Ashida

Antagonistic and agonistic effects of indigoids on the transformation of an aryl hydrocarbon receptor

Arch Biochem Biophys4701871992008

10.1016/j.abb.2007.11.021

18086550

Peter Guengerich

Martin

McCormick

Nguyen

Glover

Bradfield

Aryl hydrocarbon receptor response to indigoids in vitro and in vivo

Arch Biochem Biophys4233093162004

10.1016/j.abb.2004.01.002

15001395

Sun

Zhou

Feng

Xie

Dual character of flavonoids in attenuating and aggravating ischemia-reperfusion-induced myocardial injury

Exp Ther Med14130713142017

10.3892/etm.2017.4670

28810591

5525640

Hubbard

Murray

Perdew

Indole and tryptophan metabolism: Endogenous and dietary routes to Ah Receptor activation

Drug Metab Dispos43152215352015

10.1124/dmd.115.064246

26041783

4576673

Kewley

Whitelaw

Chapman-Smith

The mammalian basic helix-loop-helix/PAS family of transcriptional regulators

Int J Biochem Cell Biol361892042004

10.1016/S1357-2725(03)00211-5

14643885

Bock

Human AHR functions in vascular tissue: Pro- and anti-inflammatory responses of AHR agonists in atherosclerosis

Biochem Pharmacol1591161202019

10.1016/j.bcp.2018.11.021

30508524

Schmidt

Reddy

Simon

Bradfield

Characterization of a murine ahR null allele: Involvement of the Ah receptor in hepatic growth and development

Proc Natl Acad Sci USA93673167361996

10.1073/pnas.93.13.6731

8692887

Wang

Zhang

Jaeger

Krager

Bottum

Liu

Liao

Tischkau

Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure

Int J Obes (Lond)39130013092015

10.1038/ijo.2015.63

25907315

4526411

Gutiérrez-Vázquez

Quintana

Regulation of the immune response by the aryl hydrocarbon receptor

Immunity4819332018

10.1016/j.immuni.2017.12.012

29343438

5777317

Brinchmann

Skuland T Rambøl

Szoke

Brinchmann

Gutleb

Moschini

Kubátová

Kukowski

Le Ferrec

Lipophilic components of diesel exhaust particles induce Pro-inflammatory responses in human endothelial cells through AhR dependent pathway(s)

Part Fibre Toxicol15212018

10.1186/s12989-018-0257-1

29751765

5948689

Liu

Guo

Zhang

Tang

Liu

Kong

Yan

Wang

2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes endothelial cell apoptosis through activation of EP3/p38MAPK/Bcl-2 pathway

J Cell Mol Med21354035512017

10.1111/jcmm.13265

28699682

5706494

Yan

Hansson

Innate immunity, macrophage activation, and atherosclerosis

Immunol Rev2191872032007

10.1111/j.1600-065X.2007.00554.x

17850490

Ross

Atherosclerosis-an inflammatory disease

N Engl J Med3401151261999

10.1056/NEJM199901143400207

9887164

Vogel

Khan

Leung

Gershwin

Chang

Haarmann-Stemmann

Hoffmann

Denison

Cross-talk between aryl hydrocarbon receptor and the inflammatory response: A role for nuclear factor-κB

J Biol Chem289186618752014

10.1074/jbc.M113.505578

24302727

Vogel

Sciullo

Wong

Kuzmicky

Kado

Matsumura

Induction of proinflammatory cytokines and C-reactive protein in human macrophage cell line U937 exposed to air pollution particulates

Environ Health Perspect113153615412005

10.1289/ehp.8094

16263508

1310915

Ledda

González

Gulfo

Díaz Ludovico

Ramella

Toledo

Garda

Grasa

Esteve

Decreased OxLDL uptake and cholesterol efflux in THP1 cells elicited by cortisol and by cortisone through 11β-hydroxysteroid dehydrogenase type 1

Atherosclerosis25084942016

10.1016/j.atherosclerosis.2016.04.020

27187933

Huang

Guo

Zhao

Wang

Zhao

Zhang

IL-16 regulates macrophage polarization as a target gene of mir-145-3p

Mol Immunol107192019

10.1016/j.molimm.2018.12.027

30634164

Sieve

Ricke-Hoch

Kasten

Battmer

Stapel

Falk

Leisegang

Haverich A Scherr

Hilfiker-Kleiner

A positive feedback loop between IL-1β, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages

Vascul Pharmacol10316282018

10.1016/j.vph.2018.01.005

29371126

Abdolmaleki

Gheibi Hayat

Bianconi

Johnston

Sahebkar

Atherosclerosis and immunity: A perspective

Trends Cardiovasc Med28S105017382018(Epub ahead of print)

Ohtsuka

Miyashita

Shirai

Lipids deposited in human atheromatous lesions induce apoptosisof human vascular smooth muscle cells

J Atheroscler Thromb132562622006

10.5551/jat.13.256

17146154

Baumer

McCurdy

Weatherby

Mehta

Halbherr

Yamazaki

Boisvert

Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis

Nat Commun811292017

10.1038/s41467-017-01186-z

29066718

5654750

Barnes

Farndale

Collagens and atherosclerosis

Exp Gerontol345135251999

10.1016/S0531-5565(99)00038-8

10817807

Chitra

Saiprasad

Manikandan

Sudhandiran

Berberine inhibits smad and non-smad signaling cascades and enhances autophagy against pulmonary fibrosis

J Mol Med (Berl)93101510312015

10.1007/s00109-015-1283-1

25877860

Rabson

Germino

Gallo

Tian

Mechanism of suppression of cytochrome P-4501A1 expression by tumor necrosis Factor-α and lipopolysaccharide

J Biol Chem27639638396442001

10.1074/jbc.M106286200

11470802

Aung

Lame

Gohil

Denison

Rutledge

Wilson

Comparative gene responses to collected ambient particles in vitro: Endothelial responses

Physiol Genomics439179292011

10.1152/physiolgenomics.00051.2011

21652769

4631546

Vogel

Matsumura

A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-ĸB family

Biochem Pharmacol777347452009

10.1016/j.bcp.2008.09.036

18955032

Vogel

Sciullo

Wong

Lazennec

Matsumura

RelB, a new partner of aryl hydrocarbon receptor-mediated transcription

Mol Endocrinol21294129552007

10.1210/me.2007-0211

17823304

2346533

Wang

Petriello

Zhu

Hennig

PCB 126 induces monocyte/macrophage polarization and inflammation through ahR and NF-κB pathways

Toxicol Appl Pharmacol36771812019

10.1016/j.taap.2019.01.005

30768972

Hennig

Meerarani

Slim

Toborek

Daugherty

Silverstone

Robertson

Proinflammatory properties of coplanar PCBs: In vitro and in vivo evidence

Toxicol Appl Pharmacol1811741832002

10.1006/taap.2002.9408

12079426

Yisireyili

Saito

Abudureyimu

Adelibieke

Nishijima

Takeshita

Murohara

Niwa

Indoxyl sulfate-induced activation of (Pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells

PLoS One9e1092682014

10.1371/journal.pone.0109268

25343458

4208748

Hennig

Hammock

Slim

Toborek

Saraswathi

Robertson

PCB-induced oxidative stress in endothelial cells: Modulation by nutritients

Int J Hyg Environ Health205951022002

10.1078/1438-4639-00134

12018021

Watanabe

Tatebe

Namba

Koizumi

Yamazaki

Morita

Activation of aryl hydrocarbon receptor mediates indoxyl sulfate-induced monocyte chemoattractant Protein-1 expression in human umbilical vein endothelial Cells

Circ J772242302013

10.1253/circj.CJ-12-0647

23037589

Puga

Barnes

Chang

Zhu

Nephew

Khan

Shertzer

Activation of transcription factors activator protein-1 and nuclear factor-κB by 2,3,7,8-tetrachlorodibenzo-p-dioxin

Biochem Pharmacol5999710052000

10.1016/S0006-2952(99)00406-2

10692565

Chistiakov

Melnichenko

Myasoedova

Grechko

Orekhov

Mechanisms of foam cell formation in atherosclerosis

J Mol Med95115311652017

10.1007/s00109-017-1575-8

28785870

Chan

Watts

Ooi

Johnson

Barrett

Atorvastatin and fenofibrate have comparable effects on VLDL-Apolipoprotein C-III kinetics in men with the metabolic syndrome

Arterioscler Thromb Vasc Biol28183118372008

10.1161/ATVBAHA.108.170530

18566295

2734980

Mesnage

Biserni

Balu

Frainay

Poupin

Jourdan

Wozniak

Xenakis

Mein

Antoniou

Integrated transcriptomics and metabolomics reveal signatures of lipid metabolism dysregulation in hepaRG liver cells exposed to PCB 126

Arch Toxicol92253325472018

10.1007/s00204-018-2235-7

29947894

6063328

Podechard

Le Ferrec

Rebillard

Fardel

Lecureur

NPC1 repression contributes to lipid accumulation in human macrophages exposed to environmental aryl hydrocarbons

Cardiovasc Res823613702009

10.1093/cvr/cvp007

19131362

Ambolet-Camoit

Ottolenghi

Leblanc

Kim

Letourneur

Jacques

Cagnard

Guguen-Guillouzo

Barouki

Aggerbeck

Two persistent organic pollutants which act through different xenosensors (alpha-endosulfan and 2,3,7,8 tetrachlorodibenzo-p-dioxin) interact in a mixture and downregulate multiple genes involved in human hepatocyte lipid and glucose

Biochimie11679912015

10.1016/j.biochi.2015.07.003

26159488

Yao

Wang

Zhang

Peng

Liu

Zhang

Liu

Jiang

Zhu

Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice

Hepatology64921052016

10.1002/hep.28518

26928949

Van Breda

SGJ

Claessen

SMH

van Herwijnen

Theunissen

DHJ

Jennen

DGJ

de Kok

TMCM

Kleinjans

JCS

Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction

Toxicology3931601702018

10.1016/j.tox.2017.11.013

29154799

Zhang

Hatzakis

Nichols

Hao

Correll

Smith

Chiaro

Perdew

Patterson

Metabolomics reveals that aryl hydrocarbon receptor activation by environmental chemicals induces systemic metabolic dysfunction in mice

Environ Sci Technol49806780772015

10.1021/acs.est.5b01389

26023891

4890155

Yan

Liu

Garbacz

Wang

Xie

Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing FGF21

Hepatology61190819192015

10.1002/hep.27719

25614121

4441569

Kurtz

Fannin

Toth

Pearson

Vickers

Sethupathy

Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver

Sci Rep5129112015

10.1038/srep12911

26246194

4526858

Wahlang

Falkner

Gregory

Ansert

Young

Conklin

Bhatnagar

McClain

Cave

Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice

J Nutr Biochem24158715952013

10.1016/j.jnutbio.2013.01.009

23618531

3743953

Han

Toborek

Hennig

EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes

Toxicol Appl Pharmacol2611811882012

10.1016/j.taap.2012.03.024

22521609

3358429

Wang

Yang

Ramesh

Roberts

Zhou

Lin

Zhao

Guo

Overexpression of Cu/Zn-superoxide dismutase and/or catalase accelerates benzo(a)pyrene detoxification by upregulation of the aryl hydrocarbon receptor in mouse endothelial cells

Free Radic Biol Med47122112292009

10.1016/j.freeradbiomed.2009.08.001

19666105

2846758

Kim

Pjanic

Nguyen

Miller

Iyer

Liu

Wang

Sazonova

Carcamo-Orive

Matic

TCF21 and the environmental sensor aryl-hydrocarbon receptor cooperate to activate a pro-inflammatory gene expression program in coronary artery smooth muscle cells

PLoS Genet13e10067502017

10.1371/journal.pgen.1006750

28481916

5439967

Liu

Wang

Liu

Shi

Guo

Brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 cooperates with glycogen synthase kinase-3β to regulate osteogenesis of bone-marrow mesenchymal stem cells in type 2 diabetes

Mol Cell Endocrinol440931052016

10.1016/j.mce.2016.10.001

27717746

Wnuk

Kajta

Steroid and xenobiotic receptor signalling in apoptosis and autophagy of the nervous system

Int J Mol Sci18E23942017

10.3390/ijms18112394

29137141

Benjamin

Virani

Callaway

Chamberlain

Chang

Cheng

Chiuve

Cushman

Delling

Deo

American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee: Heart disease and stroke statistics-2018 update: A report from the american heart association

Circulation137e67e4922018

10.1161/CIR.0000000000000558

29386200

Zou

Xie

Yang

Pan

Adi

Liu

Chen

The association between CYP1A1 genetic polymorphisms and coronary artery disease in the uygur and han of China

Lipids Health Dis131452014

10.1186/1476-511X-13-145

25189712

4175619

Taspinar

Aydos

Sakiragaoglu

Duzen

Yalcinkaya

Oztuna

Bardakci

Tutar

Sunguroglu

Impact of genetic variations of the CYP1A1, GSTT1, and GSTM1 genes on the risk of coronary artery disease

DNA Cell Biol312112182012

10.1089/dna.2011.1252

21848428

Manfredi

Federici

Picano

Botto

Rizza

Andreassi

GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: A case-only study

Mutat Res6211061122007

10.1016/j.mrfmmm.2007.02.014

17408703

Huang

Shui

Xue

Lei

Chen

AhR expression and polymorphisms are associated with risk of coronary arterial disease in Chinese population

Sci Rep580222015

10.1038/srep08022

25620626

4306136

Peng

Xie

Impact of interaction between CYP1A1 genetic polymorphisms and smoking on coronary artery disease in the han of China

Clin Exp Hypertens393393432017

10.1080/10641963.2016.1259326

28513235

Zhang

Guo

Shi

Chi

Zhao

Wang

Gene-gene interaction between PPARG and CYP1A1 gene on coronary artery disease in the Chinese han population

Oncotarget834398344042017

28415751

5470977

Zhang

Glutathione S-transferase M1 (GSTM1) null genotype and coronary artery disease risk: A meta-analysis

Int J Clin Exp Med7337833842014

25419371

4238536

Pašalić

Marinković

Genetic polymorphisms of the CYP1A1, GSTM1, and GSTT1 enzymes and their influence on cardiovascular risk and lipid profile in people who live near a natural gas plant

Arh Hig Rada Toksikol6846522017

10.1515/aiht-2017-68-2772

28365671

Mir

Bhat

Javaid

Shah

Kumar

Sharma

Jhu

Basak

Amle

Ray

Glutathione S-transferase M1 and T1 (rs4025935 and rs71748309) null genotypes are associated with increased susceptibility to coronary artery disease in Indian Populations

Acta Cardiol716786842016

10.1080/AC.71.6.3178186

27920455

Bhat

Gandhi

Association of GSTT1 and GSTM1 gene polymorphisms with coronary artery disease in north Indian punjabi population: A case-control study

Postgrad Med J927017062016

10.1136/postgradmedj-2015-133836

27215231

Ramprasath

Senthil Murugan

Prabakaran

Gomathi

Rathinavel

Selvam

Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione-S-transferases) variants and their association to CAD in patients with type-2 diabetes

Biochem Biophys Res Commun40749532011

10.1016/j.bbrc.2011.02.097

21352813

Kim

Song

Yim

Chung

Impact of glutathione s-transferase M1 and T1 gene polymorphisms on the smoking-related coronary artery disease

J Korean Med Sci233653722008

10.3346/jkms.2008.23.3.365

18583868

2526535

Manfredi

Calvi

del Fiandra

Botto

Biagini

Andreassi

Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with type 2 diabetes mellitus

Pharmacogenomics1029342009

10.2217/14622416.10.1.29

19102712

Wang

Tang

Wang

Yan

Wang

Yang

Wang

Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking

Clin Chem Lab Med46172017252008

10.1515/CCLM.2008.353

19055448

Masetti

Botto

Manfredi

Colombo

Rizza

Vassalle

Clerico

Biagini

Andreassi

Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk

J Mol Med (Berl)814884942003

10.1007/s00109-003-0448-5

12811412

Kalpana

Rajasekharan

Menon

Modulatory effects of curcumin and curcumin analog on circulatory lipid profiles during nicotine-induced toxicity in wistar rats

J Med Food82462502005

10.1089/jmf.2005.8.246

16117619

Guo

Zhang

Cao

Zhu

Yao

Dai

Nicotine-induced upregulation of VCAM-1, MMP-2, and MMP-9 through the α7-nAChR-JNK pathway in RAW264.7 and MOVAS cells

Mol Cell Biochem39949582015

10.1007/s11010-014-2231-z

25381636

Abdel Fattah

Rizk

AAE

Motawie

Abd El-Galil

El Sebaie

Effects of nicotine on rat adrenal gland: Crosstalk between oxidative and inflammatory markers, and amelioration by melatonin

Biotech Histochem191102018

O'Donnel

Chin

Rangarajan

Xavier

Liu

Zhang

Rao-Melacini

Zhang

Pais

Agapary

Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case control study

Lancet3887617752016

10.1016/S0140-6736(16)30506-2

27431356

Zhu

Zhao

Effects of cerebral small vessel disease on the outcome of patients with ischemic stroke caused by large artery atherosclerosis

Neurol Res403813902018

10.1080/01616412.2018.1446283

29543130

Moon

Lee

Hong

Kim

CYP1A1 and GSTM1/T1 genetic variation in predicting risk for cerebral infarction

J Mol Neurosci321551592007

10.1007/s12031-007-0028-1

17873299

Demirdöğen

Adali

AÇ

Bek

Demirkaya

Adali

Cytochrome P4501A1 genotypes and smoking- and hypertension-related ischemic stroke risk

Hum Exp Toxicol324834912013

10.1177/0960327112464667

23111888

Sultana

Kolla

Peddireddy

Jeedigunta

Penagaluru

Joshi

Penagaluru

Association of cyp1a1 gene polymorphism with ischemic stroke in south Indian population

Transl Stroke Res226322011

10.1007/s12975-010-0059-8

24323584

Zhang

Yan

Ren

The association of CYP1A1 genetic polymorphisms and additional gene-gene interaction with ischemic stroke in the eastern han of China

Neurol Sci37167916842016

10.1007/s10072-016-2652-4

27383824

Sindhu

Akhter

Kochumon

Thomas

Wilson

Shenouda

Tuomilehto

Ahmad

Increased expression of the innate immune receptor TLR10 in obesity and Type-2 diabetes: Association with ROS-mediated oxidative stress

Cell Physiol Biochem455755902018

10.1159/000487034

Raza

Abbas

Ahmad

Ahmed

Zaidi

Mahdi

Association of glutathione-s-transferase (GSTM1 and GSTT1) and FTO gene polymorphisms with type 2 diabetes mellitus cases in northern India

Balkan J Med Genet1747542014

10.2478/bjmg-2014-0027

25741215

4347477

Etemad

Vasudevan

Aziz

Yusof

Khazaei

Fawzi

Jamalpour

Arkani

Mohammad

Ismail

Analysis of selected glutathione S-transferase gene polymorphisms in malaysian type 2 diabetes mellitus patients with and without cardiovascular disease

Genet Mol Res152016

10.4238/gmr.15025845

6097843

Porojan

Bala

Ilies

Catana

Popp

Dumitrascu

Combined glutathione S transferase M1/T1 null genotypes is associated with type 2 diabetes mellitus

Clujul Med881591632015

26528065

4576790

Hori

Oniki

Ueda

Goto

Mihara

Marubayashi

Nakagawa

Combined glutathione S-transferase T1 and M1 positive genotypes afford protection against type 2 diabetes in japanese

Pharmacogenomics8130713142007

10.2217/14622416.8.10.1307

17979505

Figure 1.

Structure of the AhR. The AhR consists of a bHLH/PAS domain and a TAD. AhR, aryl hydrocarbon receptor; bHLH, basic helix-loop-helix; PAS, PER-ARNT-SIM; TAD, transactivation domain; Hsp90, heat shock protein 90; NLS, nuclear localization sequence.

Figure 2.

Model of the AhR signaling pathway. Upon binding to a ligand, the AhR is activated and enters the nucleus, where it binds to ARNT on AhRE and promotes transcription of downstream genes including CYP1A1 and IL-1. AhR, aryl hydrocarbon receptor; ARNT, aryl hydrocarbon receptor nuclear translocator; AhRE, aryl hydrocarbon response element; CYP1A1, cytochrome P450 family 1 subfamily A member 1; IL-1, interleukin 1; XAP2, aryl hydrocarbon receptor interacting protein; AHRR, aryl-hydrocarbon receptor repressor; IL-11, interleukin 17; Hsp90, heat shock protein 90; p23, prostaglandin E synthase 3.

Figure 3.

Role of AhR in the pathology of atherosclerosis. Hypothesis 1: Signaling of downstream inflammatory factors such as vascular cell adhesion molecule 1 via the AhR/nuclear factor-κB signaling pathway leads to monocyte chemotaxis. Hypothesis 2: AhR promotes macrophage absorption of ox-LDL and the formation of foam cells by mediating endogenous and exogenous ligands such as ox-LDL, lipopolysaccharide and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Hypothesis 3: Increased proliferation of vascular smooth muscle cells is implicated in the occurrence of vascular complications. AhR, aryl hydrocarbon receptor; attack, pathological response induced by ligands; ox-LDL, oxidized low-density lipoprotein; p50, Rho guanine nucleotide exchange factor 7; RELA, RELA proto-oncogene NF-κB subunit; Ikbα, NF-κB inhibitor α; XAP2, aryl hydrocarbon receptor interacting protein; ARNT, aryl hydrocarbon receptor nuclear translocator; Hsp90, heat shock protein 90; p23, prostaglandin E synthase 3; CXCL1, C-X-C motif chemokine ligand 1; XRE, xenobiotic response element; SRA, scavenger receptor A.

Figure 4.

Relationship between AhR and cardiovascular disease.

Table I.

Clinical studies related to the association of AhR, CYP1A1 and GST genetic polymorphisms with atherosclerosis-related diseases.

A, Studies related to AhR and CYP1A1 polymorphisms

		AhR (NM_001621.5) CYP1A1 (KR710640.1)

Author, year	Atherosclerosis-associated disease	Country	Polymorphism	Major observation	(Refs.)
Huang et al, 2015	CAD	China	AhR allele	Significant association of AhR rs2066853 with CAD, particularly among smokers and patients with hyperlipidemia.	(69)
Peng et al, 2017		China	CYP1A1 allele	Significant association of rs4886605, rs1048943 and rs4646903 with CAD, particularly among smokers.	(70)
Zhang et al, 2017		China	CYP1A1 allele	Polymorphism in PPARG allele and interaction with CYP1A1 allele were associated with increased CAD susceptibility.	(71)
Pašalić and Marinković, 2017		Croatia	CYP1A1 m1/m2/m4	No association between polymorphisms and markers of higher risk of CAD, such as lipid parameters in the general population.	(73)
Demirdöğen et al, 2013	Ischemic stroke	Turkey	CYP1A1 allele	The 6235C allele significantly increased the susceptibility of smokers to ischemic stroke compared with non-smokers.	(87)
Moon et al, 2007		Korea	CYP1A1 allele	C allele carriers in CYP1A1have a higher risk of cerebral infarction	(86)
Sultana et al, 2011		India	CYP1A1 allele	Different genotypes showed different risk of stroke. The order was CC homozygotes (P=0.01; OR, 5.14; 95% CI, 1.14–23.14), TT (P=0.25; OR, 0.78; 95% CI, 0.51–1.19), TC (P=0.85; OR, 1.04; 95% CI, 0.67–1.60).	(88)

B, Studies related to GST polymorphisms

		GST GSTT1(CR456499.1)/M1(CR541868.1)/P1(CR450361.1)

Author, year	Atherosclerosis-associated disease	Country	Polymorphism	Major observation	(Refs.)

Zhang and Zhang, 2014	CAD	China	GSTM1 deletion	Significant association of GSTM1 with CAD, particularly among smokers.	(72)
Pašalić and Marinković, 2017		Croatia	GSTM1/T1 deletions	No significant difference in GSTT1/GSTM1 gene polymorphism in patients with CAD.	(73)
Ramprasath et al, 2011		India	GSTM1/T1 deletion GSTP1 allele	All three variants may contribute to the development of T2DM and the GSTT1 variant was involved in the development of T2DM-associated CAD complications.	(76)
Mir et al, 2016		India	GSTM1/T1 deletions	Patients with the GSTM1 null genotype have increased risk of CAD compared with patients with the GSTT1 null genotype (OR, 2.28), particularly among smokers.	(74)
Bhat et al, 2016		India	GSTM1/T1 deletions	The combined analyses of the GST genotypes showed GSTM1 null genotype significant increased risk of CAD compared with the healthy controls.	(75)
Kim et al, 2008		Korea	GSTM1/T1 deletion	Significant association of GSTM1 and GSTT1 with smoking-associated CAD.	(77)
Moon et al, 2007	Ischemic stroke	Korea	GSTM1/T1 deletions	The GST1 null genotype increased the relative risk for cerebral infarction in the subjects with the CYP1A1 C allele than those without.	(86)
Raza et al, 2014	T2DM	India	GSTT1/M1 alleles	Patients with GSTM1 positive (P=0.046) and GSTM1 null (P=0.046) have significant associations with T2DM.	(91)
Etemad et al, 2016		Malaysia	GSTT1/M1 alleles	The groups showed no significant difference in terms of allele frequencies and GST polymorphism genotype (P=0.224 and 0.119).	(92)
Porojan et al, 2015		Romania	GSTM1/T1 gene alleles	GSTT1 and GSTM1 had no effect on T2DM independently; however, the combined GSTM1/GSTT1 null genotypes were statistically significantly higher in T2DM patients compared with control subjects.	(93)
Hori et al, 2007		Japan	GSTT1/M1 gene alleles	Although each null genotype was not significantly associated with T2DM, the incidence of T2DM in patients with the GSTT1 and GSTM1 null genotypes was 1.5-fold higher than the GSTT1 and GSTM1 positive genotypes.	(94)

A χ² test and a 2×2 contingency table were applied to the calculation of P-values. P<0.05 were considered to indicate a statistically significant difference. CYP1A1, cytochrome P450 family 1 subfamily A member 1; GST, glutathione S-transferase; AhR, aryl hydrocarbon receptor; CAD, coronary artery disease; OR, odds ratio; CI, confidence interval; T2DM, type 2 diabetes mellitus; GSTM1, glutathione S-transferase µ1; GSTT1, glutathione S-transferase θ1; GSTP1, glutathione S-transferase π1.